# US 6,727,231 B1 · Uridine therapy for patients with elevated purine levels

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,727,231 B1
- Document ID: US6727231B1
- Status: Granted
- Kind: B1
- Application number: 09/689,551
- Filed: 2000-10-12
- Granted: 2004-04-27
- Earliest claimed: 2000-10-12
- Assignees: Repligen Corporation
- Inventors: Theodore M. Page; Deborah Brewer; Charles D. Moseley
- Web page: https://patentgrep.com/patent/US6727231B1

## CPC

- C12Q 1/68: involving nucleic acids
- A61K 31/7072: having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
- A61P 21/00: Drugs for disorders of the muscular or neuromuscular system
- A61P 21/02: Muscle relaxants, e.g. for tetanus or cramps
- A61P 25/00: Drugs for disorders of the nervous system
- A61P 25/08: Antiepileptics; Anticonvulsants
- A61P 25/14: for treating abnormal movements, e.g. chorea, dyskinesia
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The invention is based on the discovery that patients having elevated purine levels, e.g., individuals diagnosed with pervasive developmental disorders, such as autistic disorder, and/or neuromuscular disorders, can be treated with uridine compositions.

## Claims

### Claim 1

A method of treating an individual having an elevated purine level, the method comprising administering to the individual an effective amount of a uridine composition.

### Claim 2 (depends on 1)

A method of claim 1, wherein an effective amount of the uridine composition provides about 100 to 1500 mg of uridine/kg of body weight/day.

### Claim 3 (depends on 1)

A method of claim 1, wherein an effective amount of the uridine composition provides about 100 to 250 mg of uridine/kg of body weight/day.

### Claim 4 (depends on 1)

A method of claim 1, wherein an effective amount of the uridine composition is administered orally.

### Claim 5 (depends on 1)

A method of claim 1, wherein the individual has one or more symptoms of Pervasive Developmental Disorder (PDD).

### Claim 6 (depends on 1)

A method of claim 1, wherein the individual has one or more symptoms of autistic disorder.

### Claim 7 (depends on 1)

A method of claim 1, wherein the individual has seizures.

### Claim 8 (depends on 1)

A method of claim 1, wherein the individual has one or more symptoms of a neuromuscular disorder.

### Claim 9 (depends on 1)

A method of claim 1, wherein the patient has ataxia.

### Claim 10 (depends on 1)

The method of claim 1, wherein the uridine composition comprises uridine and a liquid ingestible carrier.

### Claim 11 (depends on 1)

The method of claim 1, wherein the uridine composition comprises triacetyl uridine.

### Claim 12 (depends on 5)

The method of claim 5, wherein the amount of the uridine composition is effective to improve one or more of the symptoms of PDD.

### Claim 13 (depends on 6)

The method of claim 6, wherein the amount of the uridine composition is effective to improve one or more of the symptoms of autistic disorder.
